Glycyrrhizic acid ( 甘草酸) 返回列表頁

參考價(jià):500

具體成交價(jià)以合同協(xié)議為準(zhǔn)

型號
HY-N0184
品牌
MCE
廠商性質(zhì)
代理商
所在地
杭州市

規(guī)格

50mg 500元 10000支可售

在線詢價(jià) 加入對比查看聯(lián)系電話

聯(lián)系方式：鄧女士查看聯(lián)系方式

更新時(shí)間：2024-06-26 10:42:50瀏覽次數(shù)：199次

聯(lián)系我時(shí)，請告知來自制藥網(wǎng)

CAS號	1405-86-3	產(chǎn)地	國產(chǎn)
規(guī)格	50mg	級別	化工級
證書	ISO系列證書

CAS號

1405-86-3

產(chǎn)地

國產(chǎn)

規(guī)格

50mg

級別

化工級

證書

ISO系列證書

Glycyrrhizic acid (Synonyms: 甘草酸; Glycyrrhizin)

Glycyrrhizic acid 是甘草里面的活性成分三萜皂苷，為 HMGB1 的拮抗劑，有用于zhong瘤、糖尿病等研究的潛力。

生物活性

Glycyrrhizic acid is a triterpenoid saponinl, acting as a direct HMGB1 antagonist, with anti-tumor, anti-diabetic activities.

體外研究(In Vitro)

Glycyrrhizic acid shows a series of anti-cancer-related pharmacological activities, such as broad-spectrum anti-cancer ability, resistance to the tissue toxicity caused by chemotherapy and radiation, drug absorption enhancing effects and anti-multidrug resistance (MDR) mechanisms, as a carrier material in drug delivery systems^[1].
In intestinal NCI-H716 cells that secretes GLP-1, Glycyrrhizic acid promotes GLP-1 secretion with a marked elevation of calcium levels. Glycyrrhizic acid can enhance GLP-1 secretion through TGR5 activation^[2].
Glycyrrhizic acid can form a stable transparent low-molecular-weight hydrogels (LMWHs) at 37°C in physiological phosphate buffered saline (PBS) with nanoclusters as the microstructures^[4].

體內(nèi)研究(In Vivo)

n type 1-like diabetic rats induced by streptozotocin (STZ-treated rats), Glycyrrhizic acid increases the level of plasma GLP-1, which is blocked by triamterene at a dose sufficient to inhibit Takeda G-protein-coupled receptor 5 (TGR5)^[1]. Glycyrrhizic acid (Glycyrrhizic acid; 50 mg/kg, i.p.) significantly decreases the levels of TgAb, HMGB1, TNF-α, IL-6, IL-1β in mice^[3].

分子量：822.93

Formula：C₄₂H₆₂O₁₆

CAS 號：1405-86-3

中文名稱：甘草酸；甘草皂甙；甘草甜素；強(qiáng)力寧；甘草皂苷

運(yùn)輸條件：Room temperature in continental US; may vary elsewhere.

儲(chǔ)存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性數(shù)據(jù)

In Vitro:

DMSO : 500 mg/mL (607.59 mM; Need ultrasonic)

H₂O : < 0.1 mg/mL (insoluble)

配制儲(chǔ)備液

濃度溶劑體積質(zhì)量	1 mg	5 mg	10 mg

1 mM	1.2152 mL	6.0759 mL	12.1517 mL
5 mM	0.2430 mL	1.2152 mL	2.4303 mL
10 mM	0.1215 mL	0.6076 mL	1.2152 mL

請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液；一旦配成溶液，請分裝保存，避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 儲(chǔ)存時(shí)，請?jiān)?6 個(gè)月內(nèi)使用，-20°C 儲(chǔ)存時(shí)，請?jiān)?1 個(gè)月內(nèi)使用。

In Vivo:

以下溶解方案都請先按照 In Vitro 方式配制澄清的儲(chǔ)備液，再依次添加助溶劑：

——為保證實(shí)驗(yàn)結(jié)果的可靠性，澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件，適當(dāng)保存；體內(nèi)實(shí)驗(yàn)的工作液，建議您現(xiàn)用現(xiàn)配，當(dāng)天使用；以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比；如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象，可以通過加熱和/或超聲的方式助溶

1.

請依序添加每種溶劑： 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 22.5 mg/mL (27.34 mM); Clear solution
2.

請依序添加每種溶劑： 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: 10 mg/mL (12.15 mM); Suspended solution; Need ultrasonic
3.

請依序添加每種溶劑： 10% DMSO 90% corn oil
Solubility: 10 mg/mL (12.15 mM); Suspended solution; Need ultrasonic

參考文獻(xiàn)

[1]. Su X, et al. Glycyrrhizic acid: A promising carrier material for anticancer therapy. Biomed Pharmacother. 2017 Sep 5;95:670-678 [Content Brief]

[2]. Wang LY, et al. Glycyrrhizic acid increases glucagon like peptide-1 secretion via TGR5 activation in type 1-like diabetic rats. Biomed Pharmacother. 2017 Sep 4;95:599-604. [Content Brief]

[3]. Li C, et al. Glycyrrhizin, a Direct HMGB1 Antagonist, Ameliorates Inflammatory Infiltration in a Model of Autoimmune Thyroiditis via Inhibition of TLR2-HMGB1 Signaling. Thyroid. 2017 May;27(5):722-731. [Content Brief]

[4]. Xia Zhao, et al. A Simple Injectable Moldable Hydrogel Assembled from Natural Glycyrrhizic Acid with Inherent Antibacterial Activity. ACS Appl. Bio Mater. 2020, 3, 1, 648–653.

注:產(chǎn)品僅用于科研